top | item 42913452

(no title)

oaktrout | 1 year ago

To emphasize your point, I don't think anyone will notice if someone's alzheimers is 2.3% better.

These rating scales like CDR-SB (invented by drug companies or researchers who are funded by drug companies) are very good at making the tiniest improvement sound significant.

discuss

order

No comments yet.